Tel Aviv University researchers are able to encode cell therapy to target specific diseases without causing toxic side effects on the liver. Their first example encapsulates mRNA nanoparticles in lipids that are only absorbed in the intestine, telling it to generate IL-10 for curing colitis and Crohn’s disease.
https://en-lifesci.tau.ac.il/news/sbcr_peer_mrna_2025
https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202408744